Test Price
2,800 AED✅ Home Collection Available
TRMU Gene Transient Infantile Liver Failure Genetic Test in UAE – 2800 AED – DHA Licensed
Executive Summary & Core Metrics
Comprehensive TRMU gene sequencing for transient infantile liver failure with integrated genetic counselling.
- Diagnostic Accuracy: >99.9% sensitivity via ISO 15189 accredited next‑generation sequencing.
- Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM.
- Post‑Test Guidance: Telephonic result interpretation and clinical follow‑up by a Consultant Medical Genetics.
- Insurance & Billing: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The TRMU gene transient infantile liver failure genetic test employs next‑generation sequencing (NGS) to detect pathogenic variants in the TRMU gene. This analysis provides a definitive molecular diagnosis for infants presenting with acute, reversible liver failure, enabling early intervention and tailored surveillance. The assay covers the full coding region, splice sites, and flanking intronic regions.
| Feature | Our Test (NGS) | Sanger Sequencing Panel |
|---|---|---|
| Method | Next‑generation sequencing (full gene analysis) | Sanger sequencing (targeted exons only) |
| Variant Detection | >99.9% sensitivity for all variant types | ~95% for known mutations; may miss deep intronic or copy number variants |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Price | 2,800 AED | Varies (often higher with add‑on segments) |
This test is ordered in collaboration with paediatricians, gastroenterologists, and clinical geneticists. A comprehensive genetic counselling session, including pedigree analysis, is mandatory prior to testing.
Physician Insight & Safety Protocols
“The TRMU NGS test provides a definitive genetic explanation for transient infantile liver failure, but results must be interpreted together with clinical symptoms, liver biochemistry, and metabolic work‑up. A positive finding guides tailored monitoring and avoids unnecessary investigations; a negative result does not exclude all metabolic aetiologies.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Do not alter or discontinue any prescribed medication without consulting the treating physician. Genetic testing does not replace acute clinical management or emergency care.
Safety Exclusion & Emergency Red Flags
- Exclusion Criteria: Patients with acute liver failure requiring immediate hospitalisation; individuals unable to provide informed consent; minors without legal guardian consent.
- Red Flag Symptoms (seek emergency care immediately): Progressive jaundice, persistent vomiting, lethargy, hypoglycaemia, unexplained bleeding or coagulopathy, signs of sepsis.
Patient FAQ & Clinical Guidance
1. What does the TRMU gene test detect?
This NGS test identifies pathogenic mutations in the TRMU gene that cause transient infantile liver failure. It analyses the full coding region and intron‑exon boundaries for known disease‑associated variants.
2. How is the sample collected and what preparation is needed?
A routine blood draw or fingertip blood spot on an FTA card is used. No fasting is required. If extracted DNA is already available, it can be submitted directly for analysis.
3. What does a positive result mean for my child's health?
A positive result confirms a genetic predisposition to transient infantile liver failure and enables the medical team to monitor liver function during infancy, manage acute episodes promptly, and avoid unnecessary invasive investigations.
4. Is genetic counselling provided before and after testing?
Yes. A mandatory genetic counselling session with a Consultant Medical Genetics is conducted before sampling, and a post‑result telephonic consultation is included to explain findings and guide management.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This test and all associated processes adhere to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and safety are governed under Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Data Security: All genetic data is encrypted and stored on ISO 27001‑aligned infrastructure. Results are shared only with the ordering physician and the patient or legal guardian.
Clinical & Logistical Metadata
| Test Name | TRMU Gene Transient Infantile Liver Failure Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or FTA card blood spot |
| Methodology Used | Next‑generation sequencing (full gene analysis) |
| ICD‑10‑CM Code | K72.90 (Hepatic failure, unspecified) |
| LOINC Code | 94219‑0 (TRMU gene mutation analysis in Blood or Tissue by Molecular genetics method) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
Corporate Lab: DNA Labs UAE | ISO 9001:2015 Certified – Cert: INT/EGQ/2509DA/3139 | Home Collection Support: +971 54 548 8731 (8 AM – 11 PM Daily)
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians